Roflumilast Tablet
Product Images NDC 72162-2385

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 72162-2385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622385)

Label (Lbl721622385)
The tablet contains Roflumilast 500 mcg. It is recommended to store at 20° to 25°C with excursions permitted to 15° to 30°C. The usual dosage for adults is one tablet (500 mcg) orally once a day. It is advised to keep the medication out of the reach of children. QR Code on the package allows access to full prescribing information. Manufactured by Micro Labs Limited and Relabeled by Bryant Ranch Prepack, Inc.*
FDA Label Image

Roflumilast-fig1.jpg (Roflumilast Fig1)

Roflumilast-fig1.jpg (Roflumilast Fig1)
This text provides information on drug interactions and dose adjustments for Roflumilast and Roflumilast N-oxide. It includes recommendations for various drugs such as Cimetidine, Enoxacin, Fluvoxamine, Ketoconazole, and other medications like Budesonide, Digoxin, Montelukast, and more regarding their use with Roflumilast. It also mentions that no dose adjustment is needed for certain drugs like Formoterol, Maalox, and Warfarin. Additionally, it specifies that Rifampicin is not recommended in combination with the mentioned drugs.*
FDA Label Image

Strc (Roflumilast Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.